Table 1 Demographics and biomarker results of the study cohort
Number of subjects | Age | Gender | sAPPα | sAPPβ | p-tau | Aβ42 | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Groups | Total | NCNP | TMGH | TMNH | (M/F) | (ng/ml) | (ng/ml) | (pg/ml) | (pg/ml) | |
AD | 33 | 21 | 3 | 9 | 75.5 ± 1.5 | 15/18 | 320.6 ± 22.6 | 594.9 ± 39.7 | 89.1 ± 5.8 | 677.8 ± 34.0 |
MCI-AD | 17 | 7 | 7 | 3 | 70.6 ± 2.1 | 7/10 | 468.0 ± 66.4 | 785.4 ± 101.2 | 91.7 ± 9.5 | 562.0 ± 60.8 |
Non-AD | 27 | 18 | 3 | 6 | 72.6 ± 1.6 | 14/13 | 235.5 ± 24.9 | 417.6 ± 33.6 | 43.9 ± 3.8 | 844.3 ± 55.2 |
Dis. control | 19 | 16 | 0 | 3 | 67.5 ± 1.9 | 12/7 | 222.8 ± 25.0 | 383.6 ± 34.3 | 36.1 ± 2.7 | 1013.0 ± 71.2 |